Bioluminescent Assay for the Quantification of Cellular Glycogen Levels
Open Access
- 17 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (30) , 33072-33080
Abstract
Glycogen is a large polymer of glucose that functions as an important means of storing energy and maintaining glucose homeostasis. Glycogen synthesis and degradation pathways are highly regulated and their dysregulation can contribute to disease. Glycogen storage diseases are a set of disorders that arise from improper glycogen metabolism. Glycogen storage disease II, known as Pompe disease, is caused by a genetic mutation that leads to increased glycogen storage in cells and tissues, resulting in progressive muscle atrophy and respiratory decline for patients. One approach for treating Pompe disease is to reduce glycogen levels by interfering with the glycogen synthesis pathway through glycogen synthase inhibitors. To facilitate the study of glycogen synthase inhibitors in biological samples, such as cultured cells, a high-throughput approach for measuring cellular glycogen was developed. A bioluminescent glycogen detection assay was automated and used to measure the glycogen content in cells grown in 384-well plates. The assay successfully quantified reduced glycogen stores in cells treated with a series of glycogen synthase 1 inhibitors, validating the utility of the assay for drug screening efforts and demonstrating its value for therapy development and glycogen metabolism research.Keywords
All Related Versions
Funding Information
- Maze Therapeutics
- Promega
This publication has 19 references indexed in Scilit:
- Glycogen storage diseasesNature Reviews Disease Primers, 2023
- Discovery and Development of Small-Molecule Inhibitors of Glycogen SynthaseJournal of Medicinal Chemistry, 2020
- Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapyJournal of Molecular Medicine, 2016
- Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor ScreeningASSAY and Drug Development Technologies, 2015
- Bioluminescent Cell-Based NAD(P)/NAD(P)H Assays for Rapid Dinucleotide Measurement and Inhibitor ScreeningASSAY and Drug Development Technologies, 2014
- Glycogen metabolism in cancerBiochemical Pharmacology, 2014
- Self‐Immolative Bioluminogenic Quinone Luciferins for NAD(P)H Assays and Reducing Capacity‐Based Cell Viability AssaysChemBioChem, 2014
- Glycogen and its metabolism: some new developments and old themesBiochemical Journal, 2012
- Pompe's diseaseThe Lancet, 2008
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990